Literature DB >> 20595100

Positron emission tomography scanning: a new paradigm for the management of Hodgkin's lymphoma.

Andrea Gallamini.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20595100      PMCID： PMC2895025          DOI： 10.3324/haematol.2010.024885

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  27 in total

Review 1.  Hodgkin's lymphoma: biology and treatment strategies for primary, refractory, and relapsed disease.

Authors:  Volker Diehl; Harald Stein; Michael Hummel; Raphael Zollinger; Joseph M Connors
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2003

2.  A functional dynamic scoring model to elucidate the significance of post-induction interim fluorine-18-fluorodeoxyglucose positron emission tomography findings in patients with Hodgkin's lymphoma.

Authors:  Eldad J Dann; Rachel Bar-Shalom; Ada Tamir; Ron Epelbaum; Irit Avivi; Menachem Ben-Shachar; Diana Gaitini; Jacob M Rowe
Journal:  Haematologica       Date:  2010-04-21       Impact factor: 9.941

3.  Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma.

Authors:  Sally F Barrington; Wendi Qian; Edward J Somer; Antonella Franceschetto; Bruno Bagni; Eva Brun; Helén Almquist; Annika Loft; Liselotte Højgaard; Massimo Federico; Andrea Gallamini; Paul Smith; Peter Johnson; John Radford; Michael J O'Doherty
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-05-27       Impact factor: 9.236

4.  Interim positron emission tomography scan in Hodgkin lymphoma: definitions, interpretation rules, and clinical validation.

Authors:  Andrea Gallamini; Francesca Fiore; Roberto Sorasio; Michel Meignan
Journal:  Leuk Lymphoma       Date:  2009-11

5.  Tumor-associated macrophages and survival in classic Hodgkin's lymphoma.

Authors:  Christian Steidl; Tang Lee; Sohrab P Shah; Pedro Farinha; Guangming Han; Tarun Nayar; Allen Delaney; Steven J Jones; Javeed Iqbal; Dennis D Weisenburger; Martin A Bast; Andreas Rosenwald; Hans-Konrad Muller-Hermelink; Lisa M Rimsza; Elias Campo; Jan Delabie; Rita M Braziel; James R Cook; Ray R Tubbs; Elaine S Jaffe; Georg Lenz; Joseph M Connors; Louis M Staudt; Wing C Chan; Randy D Gascoyne
Journal:  N Engl J Med       Date:  2010-03-11       Impact factor: 91.245

6.  [(18)F]FDG PET monitoring of tumour response to chemotherapy: does [(18)F]FDG uptake correlate with the viable tumour cell fraction?

Authors:  Karoline Spaepen; Sigrid Stroobants; Patrick Dupont; Guy Bormans; Jan Balzarini; Gregor Verhoef; Luc Mortelmans; Peter Vandenberghe; Christine De Wolf-Peeters
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-02-25       Impact factor: 9.236

Review 7.  Fluorine-18-fluorodeoxyglucose positron emission tomography for interim response assessment of advanced-stage Hodgkin's lymphoma and diffuse large B-cell lymphoma: a systematic review.

Authors:  Teruhiko Terasawa; Joseph Lau; Stéphane Bardet; Olivier Couturier; Tomomitsu Hotta; Martin Hutchings; Takashi Nihashi; Hirokazu Nagai
Journal:  J Clin Oncol       Date:  2009-03-09       Impact factor: 44.544

8.  T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model.

Authors:  Antonio Di Stasi; Biagio De Angelis; Cliona M Rooney; Lan Zhang; Aruna Mahendravada; Aaron E Foster; Helen E Heslop; Malcolm K Brenner; Gianpietro Dotti; Barbara Savoldo
Journal:  Blood       Date:  2009-04-17       Impact factor: 22.113

9.  Report on the First International Workshop on Interim-PET-Scan in Lymphoma.

Authors:  Michel Meignan; Andrea Gallamini; Michel Meignan; Andrea Gallamini; Corinne Haioun
Journal:  Leuk Lymphoma       Date:  2009-08

10.  Stromal gene signatures in large-B-cell lymphomas.

Authors:  G Lenz; G Wright; S S Dave; W Xiao; J Powell; H Zhao; W Xu; B Tan; N Goldschmidt; J Iqbal; J Vose; M Bast; K Fu; D D Weisenburger; T C Greiner; J O Armitage; A Kyle; L May; R D Gascoyne; J M Connors; G Troen; H Holte; S Kvaloy; D Dierickx; G Verhoef; J Delabie; E B Smeland; P Jares; A Martinez; A Lopez-Guillermo; E Montserrat; E Campo; R M Braziel; T P Miller; L M Rimsza; J R Cook; B Pohlman; J Sweetenham; R R Tubbs; R I Fisher; E Hartmann; A Rosenwald; G Ott; H-K Muller-Hermelink; D Wrench; T A Lister; E S Jaffe; W H Wilson; W C Chan; L M Staudt
Journal:  N Engl J Med       Date:  2008-11-27       Impact factor: 91.245
View more
  13 in total

Review 1.  Positron Emission Tomography (PET) in Oncology.

Authors:  Andrea Gallamini; Colette Zwarthoed; Anna Borra
Journal:  Cancers (Basel)       Date:  2014-09-29       Impact factor: 6.639

Review 2.  FDG PET/CT imaging as a biomarker in lymphoma.

Authors:  Michel Meignan; Emmanuel Itti; Andrea Gallamini; Anas Younes
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-01-09       Impact factor: 9.236

Review 3.  Imaging in Lymphoma: The Key Role of Fluorodeoxyglucose-Positron Emission Tomography.

Authors:  Michel Meignan; Martin Hutchings; Lawrence H Schwartz
Journal:  Oncologist       Date:  2015-07-14

4.  Baseline metabolic tumour volume in Hodgkin lymphoma: the prognostic value of accessory cells.

Authors:  Michel Meignan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-09       Impact factor: 9.236

5.  The role of 18F-FDG PET/CT in pediatric lymph-node acute lymphoblastic leukemia involvement.

Authors:  Angelina Cistaro; Francesco Saglio; Sebastian Asaftei; Piercarlo Fania; Massimo Berger; Franca Fagioli
Journal:  Radiol Case Rep       Date:  2015-11-06

6.  Plasma thymus and activation-regulated chemokine as an early response marker in classical Hodgkin's lymphoma.

Authors:  Wouter J Plattel; Anke van den Berg; Lydia Visser; Anne-Marijn van der Graaf; Jan Pruim; Hans Vos; Bouke Hepkema; Arjan Diepstra; Gustaaf W van Imhoff
Journal:  Haematologica       Date:  2011-11-04       Impact factor: 9.941

7.  Therapy of Hodgkin's lymphoma in clinical practice: A retrospective long-term follow-up analysis.

Authors:  Sara Aquino; Marino Clavio; Edoardo Rossi; Luana Vignolo; Maurizio Miglino; Mauro Spriano; Letizia Canepa; Gioacchino Catania; Ivana Pierri; Micaela Bergamaschi; Roberta Gonella; Carlo Marani; Omar Racchi; Marina Cavaliere; Riccardo Goretti; Federico Carbone; Andrea Bruzzone; Rodolfo Tassara; Angelo Michele Carella; Riccardo Ghio; Marco Gobbi
Journal:  Oncol Lett       Date:  2011-01-21       Impact factor: 2.967

8.  Randomized phase III trial of ABVD versus Stanford V with or without radiation therapy in locally extensive and advanced-stage Hodgkin lymphoma: an intergroup study coordinated by the Eastern Cooperative Oncology Group (E2496).

Authors:  Leo I Gordon; Fangxin Hong; Richard I Fisher; Nancy L Bartlett; Joseph M Connors; Randy D Gascoyne; Henry Wagner; Patrick J Stiff; Bruce D Cheson; Mary Gospodarowicz; Ranjana Advani; Brad S Kahl; Jonathan W Friedberg; Kristie A Blum; Thomas M Habermann; Joseph M Tuscano; Richard T Hoppe; Sandra J Horning
Journal:  J Clin Oncol       Date:  2012-11-26       Impact factor: 44.544

9.  Prognostic Value of FDG-PET, Based on the Revised Response Criteria, in Patients with Malignant Lymphoma: A Comparison with CT/MRI Evaluations, Based on the International Working Group/Cotswolds Meeting Criteria.

Authors:  Kayako Isohashi; Mitsuaki Tatsumi; Hiroki Kato; Kentaro Fukushima; Tetsuo Maeda; Tadashi Watabe; Eku Shimosegawa; Yuzuru Kanakura; Jun Hatazawa
Journal:  Asia Ocean J Nucl Med Biol       Date:  2015

10.  The role of fluorodeoxyglucose positron emission tomography-computerized tomography in resolving therapeutic dilemmas in pediatric Hodgkin lymphoma.

Authors:  Rachna Seth; Kriti Puri; Prashant Singh; Panneer Selvam; Rakesh Kumar
Journal:  Indian J Nucl Med       Date:  2012-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.